-
- Research/Project Funding Opportunity
- Posted 3 days ago
Notice of Termination of PAR-22-135 "NEI Regenerative Medicine Clinical Trial Planning Grant (R34 - Clinical Trials Not Allowed)"
at National Institutes of Health in United States -
- Research/Project Funding Opportunity
- Posted 4 months ago
Notice of Termination of RFA-NS-24-028: BRAIN Initiative Connectivity across Scales Data Coordinating Center (BRAIN CONNECTS DCC) (U24 Clinical Trial Not Allowed)
at National Institutes of Health in United States -
- Research/Project Funding Opportunity
- Posted 7 months ago
Notice of Change: Termination of RFA-MH-22-145, BRAIN Initiative: Standards to Define Experiments Related to the BRAIN Initiative (R01 Clinical Trial Not Allowed)
at National Institutes of Health in United States -
- Research/Project Funding Opportunity
- Posted 8 months ago
Notice of Termination of RFA-TR-23-016 Preclinical Proof of Concept Studies for Rare Diseases (R21 Clinical Trial Not Allowed)
at National Institutes of Health in United States -
- Research/Project Funding Opportunity
- Posted 1 year ago
Notice of Termination of PAR-21-340 "Limited Competition: High Impact Specialized Innovation Programs in Clinical and Translational Science for UM1 CTSA Hub Awards (RC2 Clinical Trial Not Allowed)
at National Institutes of Health in United States -
- Research/Project Funding Opportunity
- Posted 1 year ago
Notice of Termination of PAR-22-111- Early-Stage Preclinical Validation of Therapeutic Leads for Diseases of Interest to the NIDDK (R01 Clinical Trial Not Allowed)
at National Institutes of Health in United States -
- Research/Project Funding Opportunity
- Posted 1 year ago
Notice of Termination of RFA-TR-22-013 Emergency Awards: HEAL Initiative- New Innovator Award (DP2 Clinical Trial Not Allowed)
at National Institutes of Health in United States -
- Contract/Tender
- Posted 1 year ago
Notice of Termination of RFA-TR-22-011 HEAL Initiative-Early-Stage Discovery of New Pain and Opioid Use Disorder Targets Within the Understudied Druggable Proteome (R21)
at National Institutes of Health in United States -
- Research/Project Funding Opportunity
- Posted 1 year ago
Notice of Termination of PAR-22-100 "Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R03 Clinical Trial Not Allowed)
at National Institutes of Health in United States -
- Research/Project Funding Opportunity
- Posted 1 year ago
Notice of Termination of PAR-22-101 "Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R21 Clinical Trial Not Allowed)
at National Institutes of Health in United States -
- Research/Project Funding Opportunity
- Posted 1 year ago
Notice of Termination for PAR-22-122: Limited Competition: Clinical and Translational Science Awards (CTSA) Consortium-Wide Centers: Resources for Rapid Demonstration and Dissemination (U24 Clinical Trials Optional)
at National Institutes of Health in United States -
- Fellowship
- Posted 2 years ago
Notice of Termination for NOT-TR-22-023 NCATS Notice of Special Interest (NOSI): Research through NCATS Clinical and Translational Science Award (CTSA) Program: High Impact Specialized Innovation Programs (RC2)
at National Institutes of Health in United States